Electromed Inc
AMEX:ELMD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
18.12
35.43
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Electromed Inc
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 156 full-time employees. The company went IPO on 2010-08-13. The firm applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The company markets SmartVest Airway Clearance System (SmartVest System) which includes SmartVest SQL and SV2100 and related products, to patients with compromised pulmonary function. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe airway clearance therapy. The SmartVest SQL is smaller, quieter and lighter with programmability and ease of use. The company offers SmartVest SQL with SmartVest Connect wireless technology. The SmartVest Connect app allows patients and healthcare teams to track therapy in real-time and collaborate on care decisions to improve therapy adherence and patient outcomes. The company also offers single patient use (SPU) SmartVest and SmartVest Wrap to health care providers.
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 156 full-time employees. The company went IPO on 2010-08-13. The firm applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The company markets SmartVest Airway Clearance System (SmartVest System) which includes SmartVest SQL and SV2100 and related products, to patients with compromised pulmonary function. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe airway clearance therapy. The SmartVest SQL is smaller, quieter and lighter with programmability and ease of use. The company offers SmartVest SQL with SmartVest Connect wireless technology. The SmartVest Connect app allows patients and healthcare teams to track therapy in real-time and collaborate on care decisions to improve therapy adherence and patient outcomes. The company also offers single patient use (SPU) SmartVest and SmartVest Wrap to health care providers.
Strong Growth: Electromed reported its 12th consecutive quarter of year-over-year revenue and profit growth, with Q1 revenue up 15% to $16.9 million.
Profitability: Operating income rose 38% to $2.7 million, and net income increased 45% to $2.1 million ($0.25 per share).
Channel Performance: Growth was broad-based, with home care revenue up 13%, distributor sales up 41%, and hospital sales up 52%.
Operational Execution: The company successfully launched a new CRM system and completed a manufacturing optimization initiative without disrupting deliveries.
Shareholder Returns: Electromed initiated a $10 million stock repurchase program in Q1.
Market Opportunity: Management highlighted a large untapped market in bronchiectasis and ongoing investments in sales force and educational campaigns.
Guidance: Management reaffirmed expectations for double-digit top-line growth and expanded operating leverage for fiscal 2026.
